Roubenoff R
NEPS Laboratory, USDA HNRCA, 711 Washington Street, Boston, MA 02111, USA.
J Nutr Health Aging. 2000;4(3):140-2.
Sarcopenia is the loss of muscle mass and strength that occurs with aging. It is a consequence of normal aging, and does not require a disease to occur, although muscle loss can be accelerated by chronic illness. Sarcopenia is a major cause of disability and frailty in the elderly. There are many candidate mechanisms leading to sarcopenia, including age-related declines in alpha-motor neurons, growth hormone production, sex steroid levels, and physical activity. In addition, fat gain, increased production of catabolic cytokines, and inadequate intake of dietary energy and protein are also potentially important causes of sarcopenia. The relative contribution of each of these factors is not yet clear. Sarcopenia can be reversed with high-intensity progressive resistance exercise, which can probably also slow its development. A major challenge in preventing an epidemic of sarcopenia-induced frailty in the future is developing public health interventions that deliver an anabolic stimulus to the muscle of elderly adults on a mass scale.
肌肉减少症是随着年龄增长而出现的肌肉质量和力量的丧失。它是正常衰老的结果,即使没有疾病也可能发生,不过慢性病会加速肌肉流失。肌肉减少症是老年人残疾和虚弱的主要原因。导致肌肉减少症的潜在机制有很多,包括与年龄相关的α运动神经元、生长激素分泌、性类固醇水平下降以及身体活动减少。此外,脂肪增加、分解代谢细胞因子产生增加以及膳食能量和蛋白质摄入不足也是肌肉减少症的潜在重要原因。这些因素各自的相对作用尚不清楚。高强度渐进性抗阻运动可以逆转肌肉减少症,可能也能减缓其发展。未来预防肌肉减少症引发的虚弱流行的一个主要挑战是制定公共卫生干预措施,大规模地对老年人的肌肉提供合成代谢刺激。